Q2 2010

Filed Aug 16, 2010 · 10-Q · 47 days after period end · 0000109657-10-000031

Q2 2010 · 10-Q

Revenue

$0.00

no prior Q2 2009 on file

Net Income

$399.00K

no prior Q2 2009 on file

EPS Diluted

$0.00

no prior Q2 2009 on file

Gross Profit$0—

Operating Income

Same quarter

no prior Q2 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2010 · filed Aug 16, 2010 · 47 d after period end

GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR